use of VIRUNIL an Ayurvedic medicie as a supportive treatment in management of COVID-19.
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: J99- Respiratory disorders in diseasesclassified elsewhere
- Registration Number
- CTRI/2020/10/028635
- Lead Sponsor
- RI ACADEMY OF SCIENCES
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Voluntarily participating in the clinical study; fully understanding and being fully informed of the study and having signed the Informed Consent Form (ICF); willingness and capability to complete all the study procedures.
Patient who are present in the stages of 1 and 2 of the COVID-19 disease.
1.Patients with Auto Immune Disorders.
2.Patients with Co morbid conditions such as Diabetes Mellitus and Hypertension.
3.Patients Under any kind of Anti-Cancer medication, Immunosuppressants.
4.Patients who are under anti-platelet medication.
5.Patients with history of Organ Transplantation.
6.Patients with compromised pulmonary function.
7.Patients receiving antiviral drugs.
8.Pregnant and lactating mothers are also excluded from the study.
9.Any other condition, where investigators jeopardize the outcomes of the trials
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method